Report #2831901

Received Mar 18, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: Age unknown
State: NC
Recovered: Unknown
Vaccinated: —
Onset: —
Days to onset: —
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
UNK	VACCINE NOT SPECIFIED (NO BRAND NAME)	UNKNOWN MANUFACTURER	UNK	—	—

Symptoms (1)

Injection site pain

Symptom narrative

injection site stinging; This spontaneous report was received from an Other health professional via a company representative and refers to a female patient of unknown age. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. Drug reactions/allergies were unknown. On an unknown date, the patient was vaccinated with Pneumococcal 21-valent Conjugate Vaccine (CAPVAXIVE) INJ 168 mcg/ml (dose, lot # and expiration date were not reported) via intramuscular (IM) route for prophylaxis. On an unknown date, the patient experienced injection site stinging at the time of administration. At the reporting time, the outcome of injection site stinging was unknown. The causal relationship between the event of injection site stinging and Pneumococcal 21-valent Conjugate Vaccine (CAPVAXIVE) was unknown. This is one of two cases from the same reporter.